This document is an excerpt from the EUR-Lex website
Document 22018D1819
Decision of the EEA Joint Committee No 55/2017 of 17 March 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1819]
Decision of the EEA Joint Committee No 55/2017 of 17 March 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1819]
Decision of the EEA Joint Committee No 55/2017 of 17 March 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1819]
OJ L 305, 29.11.2018, p. 21–22
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
29.11.2018 |
EN |
Official Journal of the European Union |
L 305/21 |
DECISION OF THE EEA JOINT COMMITTEE
No 55/2017
of 17 March 2017
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1819]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2016/952 of 15 June 2016 approving the low-risk active substance Saccharomyces cerevisiae strain LAS02 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Regulation (EU) 2016/1424 of 25 August 2016 renewing the approval of the active substance thifensulfuron-methyl in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Commission Implementing Regulation (EU) 2016/1429 of 26 August 2016 approving the active substance Bacillus amyloliquefaciens strain MBI 600, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement. |
|
(5) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
|
(1) |
the following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
|
|
(2) |
the following points are inserted after point 13zzzzzzn (Commission Implementing Regulation (EU) 2016/1426):
|
Article 2
The texts of Implementing Regulations (EU) 2016/950, (EU) 2016/952, (EU) 2016/1424 and (EU) 2016/1429 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 18 March 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 17 March 2017.
For the EEA Joint Committee
The President
Claude MAERTEN
(1) OJ L 159, 16.6.2016, p. 3.
(2) OJ L 159, 16.6.2016, p. 10.
(3) OJ L 231, 26.8.2016, p. 25.
(4) OJ L 232, 27.8.2016, p. 1.
(*1) No constitutional requirements indicated.